1

The Blue Pill and The Pharmaceutical Industry: A Risky Stake?

News Discuss 
The story of Sildenafil offers a complicated case study for stakeholders eyeing pharma. While first sales were remarkable, recent patent expiry and the rise of cheaper versions have considerably affected revenues. https://anitazsuc851968.eveowiki.com/user

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story